Echo Therapeutics (ECTE) Misses Q2 EPS by 8c

August 14, 2014 4:37 PM EDT

Echo Therapeutics (NASDAQ: ECTE) reported Q2 EPS of ($0.31), $0.08 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $19.1 million, versus $22.56 million reported last year.

For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings